ΠΡΡΡΠΎΠ΅ ΠΏΠΎΠ²ΡΠ΅ΠΆΠ΄Π΅Π½ΠΈΠ΅ ΠΏΠΎΡΠ΅ΠΊ ΠΏΡΠΈ ΡΠ΅ΠΏΡΠΈΡΠ΅: ΡΠΏΠΈΠ΄Π΅ΠΌΠΈΠΎΠ»ΠΎΠ³ΠΈΡ, ΡΠ°ΠΊΡΠΎΡΡ ΡΠΈΡΠΊΠ° ΠΈ ΠΏΠΎΠΊΠ°Π·Π°Π½ΠΈΡ ΠΊ Π·Π°ΠΌΠ΅ΡΡΠΈΡΠ΅Π»ΡΠ½ΠΎΠΉ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ
ΠΠΈΡΡΠ΅ΡΡΠ°ΡΠΈΡ
ΠΡΡΡΠΎΠ΅ ΠΏΠΎΡΠ΅ΡΠ½ΠΎΠ΅ ΠΏΠΎΠ²ΡΠ΅ΠΆΠ΄Π΅Π½ΠΈΠ΅ Π½Π°ΡΡΠ΄Ρ Ρ ΠΎΡΡΡΠΎΠΉ ΡΠ΅ΡΠ΄Π΅ΡΠ½ΠΎΠΉ Π½Π΅Π΄ΠΎΡΡΠ°ΡΠΎΡΠ½ΠΎΡΡΡΡ, ΠΠΠ ΠΈ ΡΠ½ΡΠ΅ΡΠ°Π»ΠΎΠΏΠ°ΡΠΈΠ΅ΠΉ ΡΠ²Π»ΡΠ΅ΡΡΡ ΡΠ°ΠΊΡΠΎΡΠΎΠΌ ΡΠΈΡΠΊΠ° Π½Π΅Π±Π»Π°Π³ΠΎΠΏΡΠΈΡΡΠ½ΠΎΠ³ΠΎ ΠΈΡΡ ΠΎΠ΄Π° Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ ΡΡΠΆΠ΅Π»ΡΠΌ ΡΠ΅ΠΏΡΠΈΡΠΎΠΌ. ΠΡΡΠΈΠ±ΡΡΠΈΠ²Π½Π°Ρ Π»Π΅ΡΠ°Π»ΡΠ½ΠΎΡΡΡ ΠΏΡΠΈ ΡΠ°Π·Π²ΠΈΡΠΈΠΈ ΠΎΡΡΡΠΎΠ³ΠΎ ΠΏΠΎΡΠ΅ΡΠ½ΠΎΠ³ΠΎ ΠΏΠΎΠ²ΡΠ΅ΠΆΠ΄Π΅Π½ΠΈΡ ΡΠΎΡΡΠ°Π²Π»ΡΠ΅Ρ 28.21%, Π° ΠΎΡΠ½ΠΎΡΠ΅Π½ΠΈΠ΅ ΡΠ°Π½ΡΠΎΠ² ΡΠΈΡΠΊΠ° ΡΠΌΠ΅ΡΡΠΈ — 0111=3.20 (95% ΠΠ 1.78β20.30). Π ΠΈΡΠΊ Π½Π΅Π±Π»Π°Π³ΠΎΠΏΡΠΈΡΡΠ½ΠΎΠ³ΠΎ ΠΈΡΡ ΠΎΠ΄Π° Π² Π·Π½Π°ΡΠΈΡΠ΅Π»ΡΠ½ΠΎΠΉ ΡΡΠ΅ΠΏΠ΅Π½ΠΈ Π·Π°Π²ΠΈΡΠΈΡ ΠΎΡ ΡΡΠ΅ΠΏΠ΅Π½ΠΈ… Π§ΠΈΡΠ°ΡΡ Π΅ΡΡ >
Π‘ΠΏΠΈΡΠΎΠΊ Π»ΠΈΡΠ΅ΡΠ°ΡΡΡΡ
- ΠΠ°Π·Π°ΡΠΎΠ² A.B. Π‘ΡΠ°Π±ΠΈΠ»ΠΈΠ·Π°ΡΠΈΡ ΠΊΡΠΎΠ²ΠΈ ΡΠΈΡΡΠ°ΡΠΎΠΌ Π½Π°ΡΡΠΈΡ ΠΏΡΠΈ ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ΠΈΠΈ Π³Π΅ΠΌΠΎΡΠΎΡΠ±ΡΠΈΠΈ Ρ Π±ΠΎΠ»ΡΠ½ΡΡ Ρ ΠΎΡΡΡΡΠΌΠΈ ΠΎΡΡΠ°Π²Π»Π΅Π½ΠΈΡΠΌΠΈ : ΠΌΠΎΠ½ΠΎΠ³ΡΠ°ΡΠΈΡ / Π. Π. ΠΠ°Π·Π°ΡΠΎΠ², Π. Π. Π‘Π΅Π½ΡΠΎΠ², Π. Π. ΠΠ³ΠΎΡΠΎΠ² ΠΠΊΠ°ΡΠ΅ΡΠΈΠ½Π±ΡΡΠ³: ΠΠ·Π΄-Π²ΠΎ Π£ΡΠ°Π», Π³ΠΎΡ. ΡΠ½-ΡΠ°, 2005 122^ Ρ.
- Π ΡΠ±ΠΎΠ² Π‘.Π. ΠΠ΅ΡΡΠΎΠ»ΠΎΠ³ΠΈΡ / Π‘. Π. Π ΡΠ±ΠΎΠ² .- Π‘ΠΠ±.: Π‘ΠΏΠ΅ΡΠΠΈΡ, 2000 .- 672 Ρ:
- Π‘Π΅ΠΏΡΠΈΡ: ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΠ΅, Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΡΠ΅ΡΠΊΠ°Ρ ΠΊΠΎΠ½ΡΠ΅ΠΏΡΠΈΡ, ΠΏΠ°ΡΠΎΠ³Π΅Π½Π΅Π· ΠΈ ΠΈΠ½ΡΠ΅Π½ΡΠΈΠ²Π½Π°Ρ ΡΠ΅ΡΠ°ΠΏΠΈΡ / Π. Π . ΠΠ΅Π»ΡΡΠ°Π½Π΄, Π. Π. Π ΡΠ΄Π½ΠΎΠ², Π. Π. ΠΡΠΎΡΠ΅Π½ΠΊΠΎ ΠΈ Π΄Ρ. // ΠΠ½ΡΠ΅ΠΊΡΠΈΠΈ Π² Ρ ΠΈΡΡΡΠ³ΠΈΠΈ .- 2004 .- № 2 .- Π‘. 2 17.
- Π₯ΠΎΡΠΎΡΠΈΠ»ΠΎΠ² Π‘.Π. ΠΡΠ΅Π΄ΡΠΏΡΠ΅ΠΆΠ΄Π΅Π½ΠΈΠ΅ ΠΈ Π»Π΅ΡΠ΅Π½ΠΈΠ΅ ΠΎΡΡΡΠΎΠΉ ΠΏΠΎΡΠ΅ΡΠ½ΠΎΠΉ Π½Π΅Π΄ΠΎΡΡΠ°ΡΠΎΡΠ½ΠΎΡΡΠΈ ΠΏΡΠΈ ΠΊΡΠΈΡΠΈΡΠ΅ΡΠΊΠΈΡ ΡΠΎΡΡΠΎΡΠ½ΠΈΡΡ : Π΄ΠΈΡΡΠ΅ΡΡΠ°ΡΠΈΡ. Π΄-ΡΠ° ΠΌΠ΅Π΄. Π½Π°ΡΠΊ: 14.00.37 / Π₯ΠΎΡΠΎΡΠΈΠ»ΠΎΠ² Π‘Π΅ΡΠ³Π΅ΠΉ ΠΠ²Π³Π΅Π½ΡΠ΅Π²ΠΈΡ- ΠΠ£ «ΠΠ°ΡΡΠ½ΠΎΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°ΡΠ΅Π»ΡΡΠΊΠΈΠΉ ΠΈΠ½ΡΡΠΈΡΡΡ ΠΎΠ±ΡΠ΅ΠΉ ΡΠ΅Π°Π½ΠΈΠΌΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΠΈ Π ΠΠΠ» 2008 .210 Ρ. Π‘
- Π―ΡΡΡΡΠΎΠ²ΡΠΊΠΈΠΉ Π.Π. ΠΠΈΠ±ΡΠΈΠ΄Π½ΡΠ΅ ΡΠ΅Ρ Π½ΠΎΠ»ΠΎΠ³ΠΈΠΈ Π·Π°ΠΌΠ΅ΡΡΠΈΡΠ΅Π»ΡΠ½ΠΎΠΉ ΠΏΠΎΡΠ΅ΡΠ½ΠΎΠΉ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ Π² Π»Π΅ΡΠ΅Π½ΠΈΠΈ ΠΏΠΎΠ»ΠΈΠΎΡΠ³Π°Π½Π½ΠΎΠΉ Π½Π΅Π΄ΠΎΡΡΠ°ΡΠΎΡΠ½ΠΎΡΡΠΈ: Π£ ΠΊΠ°ΡΠ΄ΠΈΠΎΡ ΠΈΡΡΡΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ Π±ΠΎΠ»ΡΠ½ΡΡ / Π.Π. Π―ΡΡΡΡΠΎΠ²ΡΠΊΠΈΠΉ- Π. Π. ΠΠ°Π·Π°ΡΠΎΠ²Π° // ΠΠ½Π΅ΡΡΠ΅Π·ΠΈΠΎΠ»ΠΎΠ³ΠΈΡ ΠΈ ΡΠ΅Π°Π½ΠΈΠΌΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΡ .- 2006 .- N 3 .- Π‘. 67 — 70-
- Acute renal failure definition^ outcome measures, animal models, fluidtherapy and information technology needs: the Second Internationa! Consensus
- Conference of the Acute Dialysis Quality Initiative (ADQI) Group ΠΠ»Π΅ΠΊΡΡΠΎΠ½Π½ΡΠΉ- ΡΠ΅ΡΡΡΡ. / R. Bellomo, C. Ronco, J.A. Kellum [et al.] Π Π΅ΠΆΠΈΠΌ Π΄ΠΎΡΡΡΠΏΠ°: http: // ccforum.com / content / 8/47 R204 .- 24.03.20 04.
- Adding a dialysis dose to continuous haemofiltration increases survival in patients with acute renal failure / P. Saudan, M. Niederberger, S. De Seigneux et al. // Kidney Int2006 Vol. 70(9) .- P. 1312 1317.
- A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation / A.S. Levey, J.P. Bosch, J.B. Lewis et al. // Ann Intern Med 1999 Vol. 130(6) .- P. 461 470.
- Anaritide in acute tubular necrosis. Auriculin Anaritide Acute Renal Failure Study Group / R.L. Allgren, T.C. Marbury, S.N. Rahman et al. // N Engl J Med 1997 .- Vol. 336 .- P. 828 834.
- Anticoagulation strategies in continuous renal replacement therapy: can the choice be evidence based? / H.M. Oudemans-van Straaten, J.P.J. Wester, A.C. de Pont et al. // Intensive Care Med .- 2006 .- Vol. 32(2) .- P. 188 202.
- APACHE II: a severity of disease classification system / W.A. Knaus, E.A. Draper, D.P. Wagner et al. // Crit Care Med .- 1985 Vol. 13 P. 818 829'.
- A positive fluid balance is associated with a worse outcome in patients with acute renal failure ΠΠ»Π΅ΠΊΡΡΠΎΠ½Π½ΡΠΉ ΡΠ΅ΡΡΡΡ. / D. Payen, A.C. de Pont, Y. Sakr [et al.] .- Π Π΅ΠΆΠΈΠΌ-Π΄ΠΎΡΡΡΠΏΠ°: http: // ccforum.com 7 content / 12 / 3 / R74 04.06.2008:
- A prospective, multicenter study of the epidemiology, management, and outcome of severe acute renal failure in a «closed» IGU system / L. Cole, R. Bellomo, W. Silvester et al. // Am J Respir Crit Care Med .- 2000 .- Vol. 162 .-P. 191−196.
- A randomized clinical trial of continuous versus intermittent dialysis for acute renal failure / R.L. Mehta, B. Mc Donald, F.B. Gabbai et al. // Kidney Int .2001 .- Vol. 60(3) .-P. 1154- 1163.
- A randomized controlled trial comparing intermittent with continuous dialysis in patients with ARF / J.J. Augustine, D. Sandy, Π’.Π. Seifert et al. // Am J Kidney Dis 2004 .- Vol: 44(6) P. 1000 1007.
- Armitage P. Statistical Methods in Medical Research (3rd ed.) / P. Armitage,
- G. Berry London: Blackwell, 1994 131 p.
- Bagshaw S.M. Early acute kidney injury and sepsis: a multicentre evaluation ΠΠ»Π΅ΠΊΡΡΠΎΠ½Π½ΡΠΉ ΡΠ΅ΡΡΡΡ., / S.M. Bagshaw, C. George, R. Bellomo .- Π Π΅ΠΆΠΈΠΌ Π΄ΠΎΡΡΡΠΏΠ°: http: // ccforum.com / content / 12 / 27 R47 .- 10.04.2008.
- Baldwin I. Blood flow reductions during continuous renal replacement therapy and circuit life / Π. Baldwin, R. Bellomo, W. Koch// Intensive Care Med .2004 .- Vol. 30(11) .- P. 2074 2079.
- Baue A.E. Multiple organ failure / A.E. Baue, E. Faist, D.E. Fiy .- New- York.: Springer, 2000 .- 712 p.
- Bicarbonate-based haemofiltration in the management of acute renal failure with lactic acidosis / P J. Hilton, J. Taylor, L.G. Forni et al. // Q J Med 1998 .- Vol. 91(4) .- P. 279 283.
- Bonegio R. Role of apoptosis in the pathogenesis of acute renal failure / R. Bonegio, W. Lieberthal // Curr Opin Nephrol Hypertens .- 2002 .- Vol. 11 .- P. 301−308:
- Bone R.C. The ACCP-SCCM consensus conference on sepsis and organ failure / R.C. Bone, W.J. Sibbald, C.L. Sprung // Chest.- 1992 .- Vol. 101(6) P: 1644−1655.
- Bonventre J. V. Ischemic acute renal failure: An inflammatory disease? / J. V. Bonventre, A. Zuk // Kidney International2004 .- Vol. 66 .- P. 480 -485.
- Brain density changes during renal replacement in critically ill patients with acute renal failure: Continuous haemofiltration versus intermittent haemodialysis / C. Ronco, R. Bellomo, A. Brendolan et al. // J Nephrol 1999 .-Vol. 12(3),.-P. 173−178.
- Brezis M. Hypoxia of the renal medulla: its implications for disease / M.
- Brezis, S. Rosen // N Engl J Med1995 Vol. 332 .- P. 647 655.
- Cockcroft D.W. Prediction of creatinine clearance from serum creatinine / D.W. Cockcroft, M. Hi Gault//Nephron 1976 Vol. 16 .- P. 31 41.
- Comparison of* two. fluid-management strategies in acute lung injury / H-P. Wiedemann, A.P. Wheeler, G.R. Bernard et al. // N Engl J Med 2006 .Vol.354.- P. 2564−2575.
- Comparison of continuous and intermittent renal replacement therapy fΒ°r acute renal failure / D.E. Uehlinger, S: Mi Jakob, P. Ferrari et al. // Nephrol Dial Transplant2005 .- Vol. 20(8) .- P. 1630 1637.
- Comparison of lactate' and bicarbonate buffered haemofiltration fluid- use in critically ill patients / A.N. Thomas, J. M: Guy, R. Kishen et al. // Nephrol Dial Transplant.- 1997 .-Vol. 12(6) .-P. 1212 1217.
- Continuous veno-venous haemofiltration without anticoagulation / S- Uchmo, N. Fealy, I. Baldwin et al:. // ASAIO J .- 2004 .- Vol. 50(1) .- P. 76 80.
- Continuous versus intermittent renal replacement therapy: a meta-analysis /
- J.A. Kellum, D.C. Angus, J.P. Johnson et al. // Intensive Care Med .- 2002 Vol. 28(1).- P. 29−37.
- Continuous versus intermittent renal" replacement therapy for critically illpatients with acute kidney injury: A meta-analysis / S. M. Bagshaw, R.
- Berthiaume, A. Delaney et al. // Crit Care Med .- 2008 Vol. 36 .- P. 610 -617.
- Davenport A. Heparin-induced thrombocytopenia during renal replacement therapy / A. Davenport // Hemodialysis Int.- 2004 .- Vol. 8(3) .- P. 295 303.
- Doolan P.D. A clinical appraisal1 of the plasma concentration and-endogenous-clearance of creatinine / P.D. Doolan, E.L. Alpen, G.B. Theil // Am J Med -1962.- Vol. 32.- P: 65 -72.
- Detection of renal blood flow abnormalities in septic and critically ill patientsusing a newly designed indwelling thermodilution renal vein catheter / M.
- Brenner, G.L. Schaer, D.L. Mallory et al. // Chest.- 1990 .- Vol. 98 .- P. 170 -179.
- De Vriese A.S. Cytokine Removal during Continuous Hemofiltration in Septic
- Patients / A.S. De Vriese // J Am Soc Nephrol .- 1999 .- Vol. 10 .- P. 846 -853.
- De Vriese A. S. Prevention and Treatment of, Acute Renal Failure in Sepsis / A. S. De Vriese // Am Soc Nephrol.- 2003 Vol. 14 .- P. 792 805.
- Early goal-directed therapy in the treatment of severe sepsis and septic shock / E. Rivers, B. Nguyen, S. Havstad et al. // N Engl J Med .- 2001 .- Vol. 345 .P. 1368−1377.
- Early haemofiltration improves survival in post-cardiotomy patients with acute renal failure / M.M. Elahi, M.Y. Lim, R.N. Joseph et al. // European J Cardio-thorac Surg .- 2004 .- Vol. 26(5) .- P. 1027 1031.
- Effect of biocompatibility of haemodialysis membranes on mortality in acute renal failure: a meta-analysis / B.L. Jaber, J. Lau, C.H. Schmid et all.'// Clin Nephrol.- 2002 .- Vol. 57(4) .- P. 274 282.
- Effects of abdominal decompression on cardiopulmonary function and visceral perfusion in patients with intra-abdominal hypertension / M.C. Chang, «P.R. Miller, R.J. DAgostino et ah. II J Trauma .- 1998 .- Vol. 44 .- P. 440 445.
- Effects of bicarbonate and- lactate buffered replacement fluids on cardiovascular outcome in CVVH patients / M. Barenbrock, M. Hausberg, F. Matzkies et al. // Kidney Int2000 Vol. 58(4) .- P. 1751 1757.
- Effects of different doses in continuous venovenous haemofiltration on outcomes of acute renal failure: a prospective randomized trial / C. Ronco, R. Bellomo, P. Hornel et al. // Lancet2000 .- Vol. 356(9223) .- P. 26 30.
- Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: A multicentre randomised study / F. Schortgen, J.C. Lacherade, F. Bruneel et al. // Lancet.- 2001 .- Vol. 357 .- P. 911 916.
- Effects of lactate-buffered and lactate free dialysate in CAVHD patients with and without liver dysfunction / A.G. McLean, A. Davenport, D. Cox et al. // Kidney Int.- 2000 .- Vol. 58(4) P. 1765 1772.
- Eisenberg R.L. Renal failure after major angiography can be avoided with hydration / R.L. Eisenberg, W.O. Bank, M.W. Hedgock // Am J Roentgenol 1981 .-Vol. 136 .-P. 859−861.
- ESPEN Guidelines on Enteral Nutrition: Intensive care / K.G. Kreymann,
- M.M. Berger, N.E.P. Deutz et al. // Spies Clinical Nutrition .- 2006 Vol. 25 .-P. 210−223.
- Gettings L.G. Outcome in post-traumatic acute renal failure when continuous therapy is applied early vs. late / L.G. Gettings, H.N. Reynolds, T- Scalea // Intensive Care Med .- 1999 .- Vol. 25(8) .- P. 805 813.
- Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease / R.A. Pauwels, A.S. Buist, P.M. Calverley, et al. // Am J Respir Crit Care Med 2001 .- Vol. 163(5) .- P. 1256 1276.
- Goldfarb S. Proinflammatory cytokines and haemofiltration membranes / S. Goldfarb, T. Golper // J Am Soc Nephrol1994 .- Vol. 5(2) P. 228 232.
- Goodman J.W.The role of continuous renal replacement therapy in the treatment of poisoning / J.W. Goodman. D.S. Goldfarb // Seminars in Dialysis2006 .- Vol. 19(5) P. 402 407.
- Has mortality from acute renal failure decreased? A systematic review of the literature / I.P. Ympa, Y. Sakr, K. Reinhart et al. // Am J Med .- 2005 .- Vol. 118 .-P. 827−832.
- Hemodialysis Membrane With a High-Molecular-Weight Cutoff and Cytokine Levels in Sepsis Complicated by Acute Renal Failure: A Phase 1 Randomized Trial / M. Haase, R. Bellomo, I. Baldwin et al. // AJKD .- 2007 .- Vol. 50 (2), .-P. 296−304.
- Haemofiltration Study: IVOIRE (high VOlume in Intensive Care) ΠΠ»Π΅ΠΊΡΡΠΎΠ½Π½ΡΠΉ ΡΠ΅ΡΡΡΡ. .- Π Π΅ΠΆΠΈΠΌ Π΄ΠΎΡΡΡΠΏΠ°: http: // clinicaltrials.gov / ct2 / show / NCT00241228 .- 17.10.2005.
- Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety / J. Hirsh, Π’.Π. Warkentin, S.G. Shaughnessy et al. // Chest.- 2001 .- Vol. 119 (1) .- P. 64 -94.
- Intensive insulin therapy and pentastarch resuscitation in severe sepsis / F.M. Brunkhorst, C. Engel, F. Bloos et al. //NEngl J Med .- 2008 .- Vol. 358 (2) P. 125- 139.
- Intensive insulin therapy in the critically ill patient / G. Van den Berghe, P. Wouters, F. Weekers et al. // N Engl J Med .- 2001 .- Vol. 345 .- P. 1359 -1367.
- Intensity of Renal Support in Critically 111 Patients with Acute Kidney Injury /
- P.M. Palevsky, J.H. Zhang, T.Z. O’Connor et al. // N Engl J Med .- 2008 .Vol. 359 .-P. 7−20.
- Interpreting the mechanism of continuous renal replacement therapy in sepsis. The peak concentration hypothesis / C. Ronco, C. Tetta, F. Mariano et al. // Artif. Organs 2003 .- Vol. 27 .- P. 792 801.
- Intrarenal blood flow distribution in hyperdynamic septic shock: Effect of norepinephrine / D. D. Giantomasso, H. Morimatsu, C.N. May et al. // Crit Care Med .- 2003 .- Vol. 31 .- P. 2509 2513.
- Kellum J.A. Use of dopamine in acute renal failure: a meta-analysis / J.A. Kellum, M. Decker / Crit Care Med 2001 .- Vol. 29(8).- P. 1526 1531.
- Kierdorf H.P. Lactate- or bicarbonate- buffered solutions in continuous extracorporeal renal replacement therapies / H.P. Kierdorf, C. Leue, S. Arns // Kidney Int1999 .- Vol. 56 (72) .- P. 32 36.
- Kwok M.H. Meta-analysis of frusemide to prevent or treat acute renal failure M.H. Kwok, D.J. Sheridan // BMJ .- 2006 .- Vol. 333 .- P: 75 65.
- Levy E.M. The effect of acute renal failure on mortality: A cohort analysis / E.M. Levy, C.M. Viscoli, R.I. Horwitz // JAMA .- 1996 .- Vol. 275 .- P. 1489 -1494.
- Lipopolysaccaride adsorption in combined therapy of patients with severe sepsis / M.B. Yaroustovsky, B. Gelfand, Z. Popok et al. // Crit care .- 2008 .-12(2) .-P. 178.
- Luyckx V.A. Dose of dialysis in acute renal failure / V.A. Luyckx, J.V. Bonventre // Sem Dialy .- 2004 .- Vol. 17(1) .- P. 30 36.
- Marshall M. Current status of dosing and= quantification of acute renal replacement therapy. Part 2: Dosing paradigms and clinical implementation. / M. Marshall//Nephrology.- 2006 .-Vol. 11(3) .-P. 181−191.
- Martin SJ. Continuous infusion of loop diuretics in the critically ill: A review, of the literature / S.J. Martin, L.H. Danziger // Crit Care Med .- 1994 .- Vol. 22 .-P. 1323−1329.
- Mehta R. L. Acute Renal Failure Definitions and Classification: Time for Change? / R.L. Mehta, G.M. Chertow // J Am Soc Nephrol .- 2003 Vol. 14 .- P. 2178−2187.
- Mehta R.L. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury ΠΠ»Π΅ΠΊΡΡΠΎΠ½Π½ΡΠΉ ΡΠ΅ΡΡΡΡ. / R.L. Mehta, J.A. Kellum, S.V. Shah .- Π Π΅ΠΆΠΈΠΌ Π΄ΠΎΡΡΡΠΏΠ°: http // ccforum.com / content /11/2 / R31 .-01.03.2007.
- Meta-analysis: low-dose dopamine increases urine output but does. not prevent renal dysfunction or death / JiO. Friedrich, N. Adhikari, M.S. Herridge et al. // Ann Intern Med .- 2005 .- Vol. 142 .- P. 510 524.
- Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study / A. Lassnigg, D: Schmidlin,
- M. Mouhieddine et al. // J* Am Soc Nephrol 2004 .- Vol. 15 .- P. 1597t1605.
- Molitoris B.A. Transitioning to Therapy in Ischemic Acute Renal Failure / Π .A. Molitoris // J, Am Soc Nephrol.- 2003 Vol. 14 .- P. 265 267.
- Outcome of critically ill patients treated with intermittent high-volume haemofiltration: a prospective cohort analysis / H.M. Oudemans-van Straaten, R.J. Bosman, J.I. van der Spoel et al. // Intensive Care Med.- 1999 .- Vol.25(8)P. 814−821.
- Potential Interventions in Sepsis-Related Acute Kidney Injury / C. Ronco, J.
- A. Kellum, R. Bellomo et al. // Clin J Am Soc Nephrol.- 2008 .- Vol. 3 P. 53I-544i
- Pilot study on the effects of high cutoff hemofiltration on the need for norepinephrine in septic patients with acute renal failure / S. Morgera, M. Haase, T. Kuss et al. // Crit Care Med .- 2006 .- Vol. 34 .- P. 2099 2104.
- Resuscitation with low volume hydroxyethylstarch 130 kDa/0.4 is not associated with acute kidney injury ΠΠ»Π΅ΠΊΡΡΠΎΠ½Π½ΡΠΉ ΡΠ΅ΡΡΡΡ. / N. Boussekey, R. Darmon, J. Langlois [et al.]. — Π Π΅ΠΆΠΈΠΌ Π΄ΠΎΡΡΡΠΏΠ°: http: // ccforum.com / content /14/2 /R40 .- 18.13.2010.
- Ricci Z. Dose of dialysis in acute renal failure / Z. Ricci, R. Bellomo, C. Ronco // Clin J Am Soc Nephrol2006 .- Vol. 1(3) P. 380 388.
- Schiffl H. Daily haemodialysis and the outcomes of acute renal failure / H.
- Schiffl, S.M. Lang, R. Fischer // N Engl J Med .- 2002 .- Vol. 346(5) .- P. 305 -310. «
- Shoji H. Extracorporeal Endotoxin Removal for the Treatment of Sepsis: Endotoxin Adsorption Cartridge (Toraymyxin) / H. Shoji // Therapeutic Aphaeresis andiDialysis .- 2007 Vol. 1 .- P. 108 114.
- Silvester W. Epidemiology, management- and5 outcome of severe acute renal failure of critical illness in Australia / W. Silvester, R. Bellomo, L. Cole. // Crit Care Med .- 2001 .- Vol. 29(10) .- P. 1910 1915.
- Small-volume resuscitation with hyperoncotic albumin: a systematic review of randomized clinical trials ΠΠ»Π΅ΠΊΡΡΠΎΠ½Π½ΡΠΉ ΡΠ΅ΡΡΡΡ. / M. Jacob, D. Chappell, P. Conzen [et al.] .- Π Π΅ΠΆΠΈΠΌ Π΄ΠΎΡΡΡΠΏΠ°: http: // ccforum.com / content / 12 / 2 / R34.- 04.03.2008.
- Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock / R.P. Dellinger, M. Ml bevy, J.M.Carlet et al. // Crit Care Med .- 2008 .- Vol. 36 P. 296 327.
- Sustained low-efficiency daily diafiltration (SLEDD-f) for critically ill patientsrequiring renal replacement therapy: towards an adequate therapy / M.R.
- Marshall, T. Ma, D. Galler et al. // Nephrol Dial Transplant.- 2004 .- Vol. 19(4).- P. 877−884.
- The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination / G.R. Bernard, A. Artigas, K.L. Brigham // Am J Respir Crit Care Med .- 1994 .- Vol. 149 .P. 818−824.
- The efficacy of loop diuretics in acute renal failure: Assessment using
- Bayesian evidence synthesis techniques / S. Sampath, J.L. Moran, P.L. Graham et al. // Crit Care Med .- 2007 Vol. 35 P. 2516−2524.
- The pathogenesis of septic acute renal failure / L. Wan, R. Bellomo, — D. D. Giantomassoa et al. // Current Opinion in Critical Care .- 2003 Vol. 9 .P. 496−502.
- The provision and practice of renal replacement therapy on adult intensive care units in the United Kingdom / S.E. Wright, A. Bodenham, A.I. Short et al. // Anaesthesia 2003 .- Vol. 58(11).- P. 1063 1069.
- The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure / J.L.Vincent, R. Moreno, J. Takala et al. // Intensive Care Med .- 1996 .- Vol. 22 .- P. 707−710.
- The use of the activated clotting time for monitoring heparin therapy in critically ill patients / JJ. De Waele, S. Van Cauwenberghe, E. Hoste et al. // Intensive Care Med 2003 .- Vol. 29(2) .- P. 325 328.
- Tight Blood Glucose Control Is Renoprotective in Critically 111 Patients / M. Schetz, I. Vanhorebeek, P.J. Wouters // J Am Soc Nephrol2008 .- Vol. 19 P. 571 -578.β’ «
- Timing of initiation of dialysis in critically ill patients with acute kidney injury / K.D. Liu, J. Himmelfarb, E. Paganini et al. // Clin J Am Soc Hephrol .2006 .- Vol. 1(5) .- P. 915−919.
- Timing of replacement therapy for acute renal failure after cardiac surgery / U. Demirkilic, E. Kuralay, M. Yenicesu et al. // J Cardiac Surg .- 2004 Vol. 19(1) .-P. 17−20.
- Tonelli M. Acute renal failure in the intensive care unit: A systematic review of the impact of dialytic modality on mortality and renal recovery / JVC- Tonelli, B. Manns, D. Feller-Kopman // Am J Kid Dis .- 2002 .- Vol. 40(5) .- P- 875 ~ 885.
- Uchino S. A multinational multicentre study of current practice of CKRT / S. Uchino, R. Bellomo // Intensive Care Medicine 2006 .- Vol. 32 (1) .- P- 10
- UNLOAD Trial Investigators. Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure / M.R. Costanzo, M.E. Guglin, M.T. Saltzberg et al. // J Am Coll Cardiol.- 2007 .- Vol. 49(6) .- P. 675−683.
- Van den Berghe G. Intensive insulin therapy in critically ill patients / G. Van den Berghe, P. Wouters, F. Weekers // N Engl J Med .- 2001 .- Vol. 345 .- P. 1359−1367.
- Wiener R.S. Benefits and Risks of Tight Glucose Control in Critically 111 Adults: A Meta-analysis / R.S. Wiener, D.C. Wiener, R.J. Larson // JAMA .2008 .- Vol. 300(8) .- P. 933 944.109